Iberdomide (CC-220) CAS:1323403-33-3 is a regulator of the E3 ubiquitin ligase complex containing Iberdomide, a derivative of Thalidomide. Iberdomide (CC-220) induces apoptosis and has antitumor and immunostimulatory activities.
Iberdomide has been extensively studied in the field of pharmaceutical research and development, particularly in the treatment of various hematological malignancies, such as multiple myeloma and lymphoma. Its mechanism of action involves the modulation of the immune system, specifically the activation of T cells and natural killer (NK) cells, which play a crucial role in the elimination of cancer cells.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.